Home › Acute Lymphoblastic Leukemia › Illinois › Chicago
Pag-aaral pangklinika para sa Acute Lymphoblastic Leukemia sa Chicago, IL
Isang pag-aaral para sa Acute Lymphoblastic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Chicago. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Nagre-recruitPhase 1/2
- Research Site, Chicago
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Nagre-recruitPhase 1
- Lurie Children's Hospital, Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- at 1 pa
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Nagre-recruitPhase 2
- University of Chicago Comprehensive Cancer Center, Chicago
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Nagre-recruitPhase 1/2
- The University of Chicago Medical Center, Chicago
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Nagre-recruitPhase 1/2
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study of CTD402 in T-ALL/LBL Patients
Nagre-recruitPhase 1/2
- University of Chicago, Chicago
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Nagre-recruitPhase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment
Nagre-recruitObservasyonal na pag-aaral
- The University of Chicago, Chicago
Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia
Nagre-recruit
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Nagre-recruitObservasyonal na pag-aaral
- Northwestern Memorial Hospital, Chicago
- Rush University Medical Center, Chicago
- University of Illinois at Chicago, Chicago
- at 2 pa
Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
Nagre-recruit
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemia
Nagre-recruitPhase 1
- University of Chicago Medical Center, Chicago
Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
Nagre-recruitPhase 2
- University of Chicago Medical Center, Chicago
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Nagre-recruitObservasyonal na pag-aaral
- Lurie Children's Hospital-Chicago, Chicago
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Nagre-recruitPhase 1
- University of Chicago, Chicago
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Nagre-recruitPhase 1/2
- Northwestern, Chicago
A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
Nagre-recruitPhase 1/2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Venetoclax Basket Trial for High Risk Hematologic Malignancies
Nagre-recruitPhase 1
- Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Nagre-recruitPhase 1
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Pag-aaral para sa Acute Lymphoblastic Leukemia sa ibang lungsod
- Houston, TX28 pag-aaral
- New York City, NY22 pag-aaral
- Seattle, WA22 pag-aaral
- Baldwin Park, CA21 pag-aaral
- Atlanta, GA20 pag-aaral
- Memphis, TN17 pag-aaral
- Philadelphia, PA16 pag-aaral
- Washington, DC16 pag-aaral
- Los Angeles, CA15 pag-aaral
- Boston, MA15 pag-aaral
- Mountain View, CA14 pag-aaral
- Durham, NC13 pag-aaral
Iba pang pag-aaral sa Chicago
- Kanser sa Suso59 pag-aaral
- Non-Small Cell Lung Cancer59 pag-aaral
- Kanser (lahat ng uri)51 pag-aaral
- Kanser sa Prostate45 pag-aaral
- Kanser sa Baga43 pag-aaral
- Metastatic Cancer42 pag-aaral
- Obesity40 pag-aaral
- Kanser sa Ovary36 pag-aaral
- Colorectal Cancer32 pag-aaral
- Stroke31 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg29 pag-aaral
- Overweight29 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.